tiprankstipranks
OmniAb (OABI)
NASDAQ:OABI
US Market

Compare OmniAb (OABI) vs. Competitors

276 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
OmniAb
$1.47
$212.83M
-4.17
-20.54%
5 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$5.98
$158.52M
-1.44
-42.28%
5 Buy
1 Hold
0 Sell
Strong Buy
Tiziana Life Sciences
$1.37
$140.25M
-4.10
51.28%
Atea Pharmaceuticals
$5.67
$451.74M
-1.84
110.78%
2 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$15.47
$755.67M
-0.19
24.07%
4 Buy
1 Hold
0 Sell
Strong Buy
Sagimet Biosciences, Inc. Class A
$5.30
$169.69M
-3.75
137.67%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OABI
OmniAb
1.47
-0.46
-23.83%
RNAC
Cartesian Therapeutics
5.98
-7.02
-54.00%
TLSA
Tiziana Life Sciences
1.18
0.38
47.50%
AVIR
Atea Pharmaceuticals
5.67
2.73
92.86%
VOR
Vor Biopharma
15.47
1.65
11.94%
SGMT
Sagimet Biosciences, Inc. Class A
5.30
2.92
122.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts